Borrowing from the anti-inflammatory properties of olive oil, Penn Engineers used a century-old chemical reaction to redesign ...

In a July 9 memo, the director of the FDA's Center for Biologics Evaluation and Research contended there was not enough ...

Nicotine vaping continues to outperform FDA-approved smoking cessation therapies in well-designed studies, including a new ...

In spite of having plagued humans for millennia, typhoid fever is rarely considered in developed countries today. But this ancient threat is still very much a danger in our modern world. According to ...

Does colchicine work for CVD or doesn’t it? That’s the question the study authors hoped to answer, but there’s little ...

NNVC NanoViricides, Inc. (NYSE:NNVC) is a clinical-stage biopharmaceutical company developing a new class of broad-spectrum antiviral drugs known as “nanoviricides”. These agents mimic cell surface ...

South Africa's government has estimated that universities and science councils could lose about $107 million in U.S. research ...

Added value of this study To the best of our knowledge, this study is the largest randomised clinical trial assessing the effect of hydroxychloroquine versus placebo added to a standard of care ...

There will probably never be a perfect treatment to cure COVID-19—but the right medications for the right patients can save lives.

Novel Coronavirus (COVID-19) : Coronavirus : The explosive rise in cases of coronavirus infection is of concern worldwide. Stay up-to-date here.

Scientists just found a major flaw in a key COVID drug study Date: July 4, 2025 Source: Rockefeller University Summary: A promising path to fighting COVID and other coronaviruses may have been ...